View clinical trials related to Psychedelic Experiences.
Filter by:This pilot study aims to 1) establish a dosing regimen for intravenous (IV) psilocybin that will allow the drug to be administered to asleep participants without awakening them; and 2) assess whether this dosing regimen produces a psychedelic experience.